Unjha Formulations Ltd
NSE: BSE: 531762
₹20.29
(-2.26%)
Thu, 09 Apr 2026, 08:36 am
Market Cap0
PE Ratio0
Dividend0
Distribution Services
Food Distributors
24.5KUnjha Formulations Analysis
dividend
- Unable to evaluate Unjha Formulations's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Unjha Formulations's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Unjha Formulations is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Unjha Formulations is profitable, therefore cash runway is not a concern.
- Unjha Formulations is profitable, therefore cash runway is not a concern.
- Unjha Formulations has no debt, it does not need to be covered by operating cash flow.
- Unjha Formulations has no debt, it does not need to be covered by short term assets.
- Unjha Formulations has no long term commitments.
- Unjha Formulations has no debt compared to 5 years ago when it was 62.5%.
- Unjha Formulations has no debt, therefore coverage of interest payments is not a concern.
- Unjha Formulations has no debt.
- High level of physical assets or inventory.
management
- The tenure for the Unjha Formulations board of directors is about average.
- Mayank's remuneration is lower than average for companies of similar size in India.
- Mayank's compensation has been consistent with company performance over the past year, both up more than 20%.
misc
- Unjha Formulations is not covered by any analysts.
past
- Unjha Formulations's 1-year earnings growth exceeds its 5-year average (156.5% vs 3.7%)
- Unjha Formulations's year on year earnings growth rate has been positive over the past 5 years.
- Unjha Formulations has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Unjha Formulations's earnings growth has exceeded the IN Personal Products industry average in the past year (156.5% vs 1.1%).
- Unjha Formulations used its assets less efficiently than the IN Personal Products industry average last year based on Return on Assets.
- Unjha Formulations's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
value
- Unjha Formulations is good value based on assets compared to the IN Personal Products industry average.
- Unjha Formulations is good value based on earnings compared to the IN Personal Products industry average.
- Unjha Formulations is good value based on earnings compared to the India market.
- BSE:531762 is up 12.6% outperforming the Personal Products industry which returned 3.7% over the past month.
- BSE:531762 is up 12.6% outperforming the market in India which returned 8% over the past month.
- 531762 underperformed the Personal Products industry which returned -5.3% over the past year.
- 531762 underperformed the Market in India which returned -14.5% over the past year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800